DK2219607T3 - Flydende LH-formuleringer - Google Patents

Flydende LH-formuleringer

Info

Publication number
DK2219607T3
DK2219607T3 DK08844750.3T DK08844750T DK2219607T3 DK 2219607 T3 DK2219607 T3 DK 2219607T3 DK 08844750 T DK08844750 T DK 08844750T DK 2219607 T3 DK2219607 T3 DK 2219607T3
Authority
DK
Denmark
Prior art keywords
formulations
liquid
Prior art date
Application number
DK08844750.3T
Other languages
English (en)
Inventor
Rita Agostinetto
Fabrizio Samaritani
Rio Alessandra Del
Joel Richard
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of DK2219607T3 publication Critical patent/DK2219607T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK08844750.3T 2007-11-01 2008-10-29 Flydende LH-formuleringer DK2219607T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07119832 2007-11-01
US448107P 2007-11-28 2007-11-28
PCT/EP2008/064679 WO2009056569A1 (en) 2007-11-01 2008-10-29 Lh liquid formulations

Publications (1)

Publication Number Publication Date
DK2219607T3 true DK2219607T3 (da) 2013-06-17

Family

ID=39167502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08844750.3T DK2219607T3 (da) 2007-11-01 2008-10-29 Flydende LH-formuleringer

Country Status (26)

Country Link
US (1) US8664369B2 (da)
EP (1) EP2219607B1 (da)
JP (1) JP5551601B2 (da)
KR (1) KR101513181B1 (da)
CN (1) CN101842083B (da)
AU (1) AU2008320844B2 (da)
BR (1) BRPI0818324B8 (da)
CA (1) CA2700662C (da)
CY (1) CY1113121T1 (da)
DK (1) DK2219607T3 (da)
EA (1) EA019432B1 (da)
EC (1) ECSP10010224A (da)
ES (1) ES2393233T3 (da)
HK (1) HK1145443A1 (da)
HR (1) HRP20120660T1 (da)
IL (1) IL205105A (da)
MX (1) MX2010004639A (da)
MY (1) MY153976A (da)
NZ (1) NZ583991A (da)
PL (1) PL2219607T3 (da)
PT (1) PT2219607E (da)
RS (1) RS52566B (da)
SI (1) SI2219607T1 (da)
UA (1) UA101484C2 (da)
WO (1) WO2009056569A1 (da)
ZA (1) ZA201001907B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102007143B (zh) 2008-01-09 2015-08-26 塞诺菲-安万特德国有限公司 具有超延迟时效特征的新型胰岛素衍生物
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc ｅＭＩＰを有効成分とする水溶性製剤
NZ597757A (en) * 2009-07-06 2014-06-27 Sanofi Aventis Deutschland Aqueous insulin preparations containing methionine
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
PT2498801T (pt) 2009-11-13 2018-05-02 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina
CN102821782B (zh) * 2010-02-12 2015-07-15 印塔斯生物制药有限公司 促卵泡激素的液体配制品
RU2546520C2 (ru) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN102293756A (zh) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 一种尿促性素冻干粉针剂及其制备方法
ES2550357T3 (es) 2011-08-29 2015-11-06 Sanofi-Aventis Deutschland Gmbh Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
RU2015130613A (ru) * 2012-12-26 2017-01-31 Вокхардт Лимитед Фармацевтическая композиция
TWI641381B (zh) 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
EP3091964A1 (en) 2014-01-09 2016-11-16 Sanofi Stabilized pharmaceutical formulations of insulin aspart
CA2932875A1 (en) 2014-01-09 2015-07-16 Sanofi Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
CN105960249B (zh) 2014-01-09 2021-03-16 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
HUE062573T2 (hu) 2014-12-12 2023-11-28 Sanofi Aventis Deutschland Glargin inzulin/lixiszenatid rögzített arányú készítmény
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
GB201603280D0 (en) * 2016-02-24 2016-04-13 Ferring Bv Stable liquid gonadotropin formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
US5681302A (en) * 1994-06-14 1997-10-28 Minnesota Mining And Manufacturing Company Elastic sheet-like composite
WO1996029095A1 (en) * 1995-03-21 1996-09-26 Applied Research Systems Ars Holding N.V. Hcg liquid formulations
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
KR20010083126A (ko) * 1998-07-23 2001-08-31 피터 지. 스트링거 여포자극 호르몬 및 여포자극 호르몬 변이체 제형, 제품및 방법
US20040224886A1 (en) * 2003-01-08 2004-11-11 Chiron Corporation Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
US7387998B2 (en) 2003-03-28 2008-06-17 New York University STQ peptides
BRPI0409532B8 (pt) * 2003-04-02 2021-05-25 Ares Trading Sa composição farmacêutica líquida, artigo de fabricação, método de fabricação de composição farmacêutica e método de fabricação de artigo de fabricação

Also Published As

Publication number Publication date
CA2700662C (en) 2015-10-13
IL205105A0 (en) 2010-11-30
AU2008320844A1 (en) 2009-05-07
ES2393233T3 (es) 2012-12-19
EA201070549A1 (ru) 2010-10-29
AU2008320844B2 (en) 2013-08-29
PL2219607T3 (pl) 2012-12-31
CY1113121T1 (el) 2016-04-13
US20100261649A1 (en) 2010-10-14
EA019432B1 (ru) 2014-03-31
EP2219607B1 (en) 2012-08-15
PT2219607E (pt) 2012-08-31
EP2219607A1 (en) 2010-08-25
RS52566B (en) 2013-04-30
US8664369B2 (en) 2014-03-04
MY153976A (en) 2015-04-30
KR20100088147A (ko) 2010-08-06
BRPI0818324B1 (pt) 2019-12-24
HK1145443A1 (en) 2011-04-21
CN101842083B (zh) 2012-11-14
BRPI0818324A2 (pt) 2017-05-16
HRP20120660T1 (hr) 2012-09-30
MX2010004639A (es) 2010-08-04
NZ583991A (en) 2012-02-24
JP5551601B2 (ja) 2014-07-16
JP2011502968A (ja) 2011-01-27
WO2009056569A9 (en) 2010-01-21
SI2219607T1 (sl) 2012-09-28
ECSP10010224A (es) 2010-07-30
UA101484C2 (en) 2013-04-10
ZA201001907B (en) 2011-05-25
CA2700662A1 (en) 2009-05-07
KR101513181B1 (ko) 2015-04-21
WO2009056569A1 (en) 2009-05-07
IL205105A (en) 2015-04-30
CN101842083A (zh) 2010-09-22
BRPI0818324B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
DK2219607T3 (da) Flydende LH-formuleringer
BRPI0814324A2 (pt) Dispositivo
BRPI0822034A2 (pt) Dispositivo
DK2114143T3 (da) Flydende sulfonylurea-herbicidformuleringer
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
BRPI0814188A2 (pt) Formulações
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
DK2789349T3 (da) Flydende præparat omfattende pimobendan
BRPI0811451A2 (pt) Exopolissacarídeo
BRPI0814519A2 (pt) Organopolissiloxano
DE602007000495D1 (de) Flüssigkeit-Koinfusionsgerät
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
AT505058A3 (de) Türschliesssystem
BRPI0812994A2 (pt) Microbiocidas
DE502008001742D1 (de) Kabelbearbeitungseinrichtung
DE112008001216A5 (de) Magnetronplasmaanlage
CU20090155A7 (es) Macrolidos
DE102007038931A8 (de) Fadenlagennähwirkstoffe
UY33138A (es) Formulaciones liquidas
AT9563U3 (de) Wirbelsäulenzuggurtung
AT504425B8 (de) Portioniersteuerung
FIU20070426U0 (fi) Apuaisa
ITVA20070044U1 (it) Abbracciatovagliolo - abbraccia tovagliolo
IT1392092B1 (it) Dispositivo di manipolazione